Thrombotic Thrombocytopenic Purpura

Alterations of Hemostasis Associated With Malignancy: Etiology, Pathophysiology, Diagnosis and Management

“…Another type of increased platelet destruction which is rarely associated with malignancy is thrombotic thrombocytopenic purpura, or TTP [24]. This rare syndrome is usually fatal when it develops in the cancer patient, but may respond to heparin, dextrans, steroids or antiplatelet drugs [30,60,97,106].…”